Bandingkan Harga & Kinerja Perdana Bangun Pusaka Tbk (KONI) vs Organon Pharma Indonesia Tbk. (SCPI)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Perdana Bangun Pusaka Tbk dan Organon Pharma Indonesia Tbk.: Perdana Bangun Pusaka Tbk diperdagangkan di Rp2.070 (kapitalisasi pasar 661,44 M, volume 24 jam 30,6 rb), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Perdana Bangun Pusaka Tbk jauh lebih besar — sekitar 6,3× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| KONI | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 661,44 M | 104,4 M |
Volume | 30,6 rb | — |
Lot | 306 | — |
Perputaran | 66,04 jt | — |
Harga Rata-rata | 2.158,17 | — |
Nilai Transaksi | 66,04 jt | — |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Perdana Bangun Pusaka Tbk
PT. Perdana Bangun Persaka Tbk conducting business in the field of photography trade business and its equipment, and capital participation in its affiliates. The company is established in 1987 and registered at the Jakarta Stock Exchange since 1995 and a sole distributor of photography products produced by Konica Corporation, Japan. Product marketed by the company are as follows: KONICA color film and photography paper, KONICA photo printing machine, KONIKA X-ray film and chemicals for photography of KONICA trade mark.
Selengkapnya di halaman KONI →Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →
